These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28286158)

  • 1. Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies.
    Perkins T; Rosenberg JM; Le Coz C; Alaimo JT; Trofa M; Mullegama SV; Antaya RJ; Jyonouchi S; Elsea SH; Utz PJ; Meffre E; Romberg N
    J Allergy Clin Immunol Pract; 2017; 5(5):1344-1350.e3. PubMed ID: 28286158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
    Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane activator and CAML interactor (TACI) haploinsufficiency results in B-cell dysfunction in patients with Smith-Magenis syndrome.
    Chinen J; Martinez-Gallo M; Gu W; Cols M; Cerutti A; Radigan L; Zhang L; Potocki L; Withers M; Lupski JR; Cunningham-Rundles C
    J Allergy Clin Immunol; 2011 Jun; 127(6):1579-86. PubMed ID: 21514638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smith-Magenis syndrome: Clinical and behavioral characteristics in a large retrospective cohort.
    Rive Le Gouard N; Jacquinet A; Ruaud L; Deleersnyder H; Ageorges F; Gallard J; Lacombe D; Odent S; Mikaty M; Manouvrier-Hanu S; Ghoumid J; Geneviève D; Lehman N; Philip N; Edery P; Héron D; Rastel C; Chancenotte S; Thauvin-Robinet C; Faivre L; Perrin L; Verloes A
    Clin Genet; 2021 Apr; 99(4):519-528. PubMed ID: 33368193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of Smith-Magenis syndrome in two fetuses with increased nuchal translucency, mild lateral ventriculomegaly, and congenital heart defects.
    Lei TY; Li R; Fu F; Wan JH; Zhang YL; Jing XY; Liao C
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):886-890. PubMed ID: 28040141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome.
    Vieira GH; Rodriguez JD; Carmona-Mora P; Cao L; Gamba BF; Carvalho DR; de Rezende Duarte A; Santos SR; de Souza DH; DuPont BR; Walz K; Moretti-Ferreira D; Srivastava AK
    Eur J Hum Genet; 2012 Feb; 20(2):148-54. PubMed ID: 21897445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonrecurrent PMP22-RAI1 contiguous gene deletions arise from replication-based mechanisms and result in Smith-Magenis syndrome with evident peripheral neuropathy.
    Yuan B; Neira J; Gu S; Harel T; Liu P; Briceño I; Elsea SH; Gómez A; Potocki L; Lupski JR
    Hum Genet; 2016 Oct; 135(10):1161-74. PubMed ID: 27386852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
    Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
    Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complex-mediated autoimmunity in a patient With Smith-Magenis syndrome (del 17p11.2).
    Yang J; Chandrasekharappa SC; Vilboux T; Smith AC; Peterson EJ
    J Clin Rheumatol; 2014 Aug; 20(5):291-3. PubMed ID: 25036569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic
    Linders CC; van Eeghen AM; Zinkstok JR; van den Boogaard MJ; Boot E
    Genes (Basel); 2023 Jul; 14(8):. PubMed ID: 37628566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.
    Vilboux T; Ciccone C; Blancato JK; Cox GF; Deshpande C; Introne WJ; Gahl WA; Smith AC; Huizing M
    PLoS One; 2011; 6(8):e22861. PubMed ID: 21857958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal brain magnetic resonance imaging in two patients with Smith-Magenis syndrome.
    Maya I; Vinkler C; Konen O; Kornreich L; Steinberg T; Yeshaya J; Latarowski V; Shohat M; Lev D; Baris HN
    Am J Med Genet A; 2014 Aug; 164A(8):1940-6. PubMed ID: 24788350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
    Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
    Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review.
    Korteling D; Musch JLI; Zinkstok JR; Boot E
    Am J Med Genet B Neuropsychiatr Genet; 2024 Mar; 195(2):e32956. PubMed ID: 37584268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smith-Magenis syndrome: Report of morphological and new functional cardiac findings with review of the literature.
    Onesimo R; Versacci P; Delogu AB; De Rosa G; Pugnaloni F; Blandino R; Leoni C; Calcagni G; Digilio MC; Zollino M; Marino B; Zampino G
    Am J Med Genet A; 2021 Jul; 185(7):2003-2011. PubMed ID: 33811726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?
    Vlangos CN; Yim DK; Elsea SH
    Mol Genet Metab; 2003 Jun; 79(2):134-41. PubMed ID: 12809645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.
    Rinaldi B; Villa R; Sironi A; Garavelli L; Finelli P; Bedeschi MF
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.
    Girirajan S; Vlangos CN; Szomju BB; Edelman E; Trevors CD; Dupuis L; Nezarati M; Bunyan DJ; Elsea SH
    Genet Med; 2006 Jul; 8(7):417-27. PubMed ID: 16845274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic difficulties in Smith-Magenis Syndrome (SMS) on the basis of own experience and literature data].
    Stembalska A; Jakubiak A; Śmigiel R
    Med Wieku Rozwoj; 2012; 16(2):138-43. PubMed ID: 22971658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periventricular nodular heterotopia in Smith-Magenis syndrome.
    Capra V; Biancheri R; Morana G; Striano P; Novara F; Ferrero GB; Boeri L; Celle ME; Mancardi MM; Zuffardi O; Parrini E; Guerrini R
    Am J Med Genet A; 2014 Dec; 164A(12):3142-7. PubMed ID: 25257626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.